| Bioactivity | tert-Butyl piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8 is the deuterium labeled tert-Butyl piperazine-1-carboxylate[1]. |
| Invitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| Name | tert-Butyl piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8 |
| CAS | 1126621-86-0 |
| Formula | C9H10D8N2O2 |
| Molar Mass | 194.30 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |
tert-Butyl piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8
CAS: 1126621-86-0 F: C9H10D8N2O2 W: 194.30
tert-Butyl piperazine-1-carboxylate-2,2,3,3,5,5,6,6-d8 is the deuterium labeled tert-Butyl piperazine-1-carboxylate.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.